Rosiglitazone treatment decreases amyloid formation following transplantation of human islet amyloid polypeptide (hIAPP) transgenic islets


Autoria(s): Udayasankar, Jayalakshmi; Hull, Rebecca L.; Zraika, Sakeneh; Aston-Mourney, Kathryn; Subramanian, Shoba L.; Taborsky, Gerald J.; Kahn, Steven E.
Contribuinte(s)

[Unknown]

Data(s)

01/01/2008

Identificador

http://hdl.handle.net/10536/DRO/DU:30049278

Idioma(s)

eng

Publicador

American Diabetes Association

Relação

http://dro.deakin.edu.au/eserv/DU:30049278/udayasankar-rosiglitazonetreatment-2008.pdf

Tipo

Conference Paper